134 related articles for article (PubMed ID: 3813188)
1. Vasodilators and pulmonary hypertension: where do we go from here?
Rubin LJ
Am Rev Respir Dis; 1987 Feb; 135(2):287. PubMed ID: 3813188
[No Abstract] [Full Text] [Related]
2. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.
Rubin LJ
Clin Chest Med; 1983 May; 4(2):309-19. PubMed ID: 6342925
[No Abstract] [Full Text] [Related]
3. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
[TBL] [Abstract][Full Text] [Related]
5. Vasodilator therapy for pulmonary hypertensive disorders.
Hyman AL; Kadowitz PJ
Chest; 1984 Feb; 85(2):145-7. PubMed ID: 6692692
[No Abstract] [Full Text] [Related]
6. Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure.
Sniderman AD; Fitchett DH
Int J Cardiol; 1988 Aug; 20(2):173-81. PubMed ID: 3061937
[No Abstract] [Full Text] [Related]
7. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
Rich S; Martinez J; Lam W; Levy PS; Rosen KM
Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
[No Abstract] [Full Text] [Related]
8. Effect of vasodilators on pulmonary vascular resistance in patients with pulmonary hypertension.
Zaloga GP; Chernow B; Holt MR; Hughes P; Pilley MP; Rainey TG; Lake CR
Clin Pharm; 1983; 2(3):265-8. PubMed ID: 6192967
[No Abstract] [Full Text] [Related]
9. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
[No Abstract] [Full Text] [Related]
10. Adverse effect of hydralazine in patients with primary pulmonary hypertension.
Kronzon I; Cohen M; Winer HE
JAMA; 1982 Jun; 247(22):3112-4. PubMed ID: 7077805
[No Abstract] [Full Text] [Related]
11. Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
Halpern SM; Shah PK; Lehrman S; Goldberg HS; Jasper AC; Koerner SK
Chest; 1987 Oct; 92(4):686-91. PubMed ID: 3652754
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension in systemic lupus erythematosus.
Gladman DD; Sternberg L
J Rheumatol; 1985 Apr; 12(2):365-7. PubMed ID: 4032410
[TBL] [Abstract][Full Text] [Related]
13. Deleterious effects of hydralazine in patients with pulmonary hypertension.
Packer M; Greenberg B; Massie B; Dash H
N Engl J Med; 1982 Jun; 306(22):1326-31. PubMed ID: 7070457
[TBL] [Abstract][Full Text] [Related]
14. The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.
Weir EK; Rubin LJ; Ayres SM; Bergofsky EH; Brundage BH; Detre KM; Elliott CG; Fishman AP; Goldring RM; Groves BM
Am Rev Respir Dis; 1989 Dec; 140(6):1623-30. PubMed ID: 2690706
[TBL] [Abstract][Full Text] [Related]
15. [Effect of the preparation CIBA 31 531-Ba on respiration and pulmonary circulation].
Jedlicka K; Daum S; Nikodýmová L; Stiksa J
Cas Lek Cesk; 1969 May; 108(21):629-33. PubMed ID: 5788079
[No Abstract] [Full Text] [Related]
16. Vasodilatory treatment of pulmonary hypertension.
Widimský J
Eur J Respir Dis; 1986 Mar; 68(3):161-6. PubMed ID: 2870937
[TBL] [Abstract][Full Text] [Related]
17. Influence of mechanical ventilation and inhalation of pulmonary vasodilators, upon pulmonary blood flow and pulmonary vascular resistance.
Kern H; Kox WJ
Cardiol Young; 2000 Mar; 10(2):166-70. PubMed ID: 10817306
[No Abstract] [Full Text] [Related]
18. Vasodilator therapy in primary pulmonary hypertension.
Elkayam U
Chest; 1981 Mar; 79(3):253-4. PubMed ID: 7471853
[No Abstract] [Full Text] [Related]
19. The case for treatment of selected patients with primary pulmonary hypertension.
Reeves JT; Groves BM; Turkevich D
Am Rev Respir Dis; 1986 Aug; 134(2):342-6. PubMed ID: 3740659
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Vasodilators and Anesthesia Considerations.
Green JB; Hart B; Cornett EM; Kaye AD; Salehi A; Fox CJ
Anesthesiol Clin; 2017 Jun; 35(2):221-232. PubMed ID: 28526144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
